Jan Otto Solem

Syntach AB is a Swedish company based in Lund that specializes in developing a revolutionary, minimally invasive long-term cardiac support device and mitral valve repair technology for people suffering from severe heart failure. Syntach has close links and extensive cooperation with various institutions at the University of Lund. The company is also developing a minimally-invasive device to correct mitral valve regurgitation, which can be used in combination with the cardiac support device or on a standalone basis. The company was founded in 2012 with the aim of creating an entirely new class of cardiac support devices to improve the care of the rapidly-growing number of people with heart failure. The company was founded by Tor Peters and Jan Otto Solem, who have been the CEOs since incorporation.